Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2372285
Max Phase: Preclinical
Molecular Formula: C50H73N13O11S2
Molecular Weight: 1096.35
Molecule Type: Unknown
Associated Items:
ID: ALA2372285
Max Phase: Preclinical
Molecular Formula: C50H73N13O11S2
Molecular Weight: 1096.35
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOc1ccc(C[C@@H]2NC(=O)CC(C)(C)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1
Standard InChI: InChI=1S/C50H73N13O11S2/c1-6-74-31-18-16-30(17-19-31)23-33-43(68)59-34(22-29-12-8-7-9-13-29)45(70)62-41(28(2)3)47(72)60-35(24-38(51)64)44(69)61-36(27-75-76-50(4,5)25-40(66)57-33)48(73)63-21-11-15-37(63)46(71)58-32(14-10-20-55-49(53)54)42(67)56-26-39(52)65/h7-9,12-13,16-19,28,32-37,41H,6,10-11,14-15,20-27H2,1-5H3,(H2,51,64)(H2,52,65)(H,56,67)(H,57,66)(H,58,71)(H,59,68)(H,60,72)(H,61,69)(H,62,70)(H4,53,54,55)/t32-,33+,34+,35+,36+,37+,41+/m1/s1
Standard InChI Key: RHLYUMPLHSJBPY-DUZRLCFHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1096.35 | Molecular Weight (Monoisotopic): 1095.4994 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Manning M, Lammek B, Bankowski K, Seto J, Sawyer WH.. (1985) Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin., 28 (10): [PMID:4045923] [10.1021/jm00148a019] |
Source(1):